中文版 English
News Center
  • Tel:027-87779578
  • Office:027-87779590
  • Address:Buliding 2,NO.390 ,Gaoxin 2nd Road,East lake High-tech Development zone,Wuhan,China
  • Email:business@biodapoct.com
Home >> News Center >> Company news >> Big News! Bioda Diagnostics (Wuhan) Co., Ltd Has Access to EU CE Market for Its Test Products against COVID-19!

Big News! Bioda Diagnostics (Wuhan) Co., Ltd Has Access to EU CE Market for Its Test Products against COVID-19!

Views: 20078 Post: 2020-03-31 16:40:51

Bioda Diagnostics (Wuhan) Co., Ltd. (hereinafter referred to as Bioda) has access to EU CE market for its test kits against COVID-19 on March 30, 2020, fighting for global epidemic resistance!

Novel Coronavirus (COVID-19) Antibody IgM/IgG Test (Colloidal Gold)



The Novel Coronavirus (COVID-19) Antibody IgM/IgG Test developed by Bioda uses colloidal gold immunochromatography technology and capture method to detect (COVID-19) IgM/IgG antibody in human body, which is used for the qualitative test of (COVID-19) IgM/IgG antibodies in human serum, plasma and venous whole blood samples in vitro. The test results will be observed with the naked eye after about 15 minutes. It can be used as a supplementary test indicator for suspected cases whose COVID-19 nucleic acid tests show negative or used in conjunction with nucleic acid tests in the diagnosis of suspected cases. The company has obtained the EU market access for this product which can be sold in many countries and regions around the world. Bioda will be dedicated to providing its own strength for global anti-epidemic!


Type:Company news

Keywords:

Bioda Diagnostics(Wuhan) Co.,LTD. all rights reserved 鄂ICP备19013949号-1 Home News Products Contact
 
XML 地图 | Sitemap 地图